Guselkumab for the treatment of Crohn’s disease: Induction results from the Phase 2 GALAXI-1 study

Title
Guselkumab for the treatment of Crohn’s disease: Induction results from the Phase 2 GALAXI-1 study
Authors
Keywords
Crohn’s Disease Activity Index, GALAXI-1, Guselkumab, Interleukin-23
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-02-05
DOI
10.1053/j.gastro.2022.01.047

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now